NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $175,600,147 | +0.9% | 1,723,936 | -0.1% | 0.01% | 0.0% |
| Q2 2023 | $174,070,482 | +16.9% | 1,725,007 | +6.6% | 0.01% | +25.0% |
| Q1 2023 | $148,859,736 | +7.1% | 1,618,041 | +5.6% | 0.00% | 0.0% |
| Q4 2022 | $138,995,582 | +31.4% | 1,532,138 | +10.1% | 0.00% | 0.0% |
| Q3 2022 | $105,772,000 | -19.0% | 1,391,569 | -9.9% | 0.00% | 0.0% |
| Q2 2022 | $130,623,000 | -4.4% | 1,545,282 | -0.7% | 0.00% | 0.0% |
| Q1 2022 | $136,587,000 | +18.7% | 1,556,539 | +18.3% | 0.00% | +33.3% |
| Q4 2021 | $115,096,000 | +1.1% | 1,315,829 | -5.5% | 0.00% | 0.0% |
| Q3 2021 | $113,813,000 | -13.4% | 1,391,690 | -3.4% | 0.00% | -25.0% |
| Q2 2021 | $131,437,000 | +23.0% | 1,440,567 | +15.2% | 0.00% | +33.3% |
| Q1 2021 | $106,870,000 | +63.3% | 1,250,230 | +80.4% | 0.00% | +50.0% |
| Q4 2020 | $65,436,000 | -23.0% | 692,949 | -29.1% | 0.00% | -33.3% |
| Q3 2020 | $85,026,000 | +3.2% | 977,772 | +3.6% | 0.00% | 0.0% |
| Q2 2020 | $82,407,000 | -3.8% | 943,517 | -9.2% | 0.00% | -25.0% |
| Q1 2020 | $85,642,000 | -79.7% | 1,038,715 | -76.7% | 0.00% | -75.0% |
| Q4 2019 | $421,637,000 | +128.1% | 4,452,811 | +109.4% | 0.02% | +100.0% |
| Q3 2019 | $184,824,000 | -59.5% | 2,126,863 | -57.5% | 0.01% | -60.0% |
| Q2 2019 | $456,637,000 | -53.2% | 5,000,961 | -50.7% | 0.02% | -54.5% |
| Q1 2019 | $975,915,000 | -0.6% | 10,150,979 | -11.3% | 0.04% | -12.0% |
| Q4 2018 | $981,607,000 | +222.2% | 11,439,298 | +223.5% | 0.05% | +284.6% |
| Q3 2018 | $304,690,000 | +5.3% | 3,536,334 | -7.7% | 0.01% | 0.0% |
| Q2 2018 | $289,286,000 | -6.9% | 3,829,570 | -0.3% | 0.01% | -13.3% |
| Q1 2018 | $310,681,000 | -7.8% | 3,842,689 | -4.3% | 0.02% | -6.2% |
| Q4 2017 | $337,146,000 | +5.8% | 4,015,562 | +8.2% | 0.02% | 0.0% |
| Q3 2017 | $318,533,000 | +7.5% | 3,710,341 | +4.5% | 0.02% | 0.0% |
| Q2 2017 | $296,299,000 | +40.8% | 3,549,783 | +25.3% | 0.02% | +33.3% |
| Q1 2017 | $210,378,000 | +539330.8% | 2,832,597 | +566419.4% | 0.01% | – |
| Q3 2016 | $39,000 | -44.3% | 500 | -41.1% | 0.00% | – |
| Q2 2016 | $70,000 | -5.4% | 849 | +4.4% | 0.00% | – |
| Q2 2014 | $74,000 | – | 813 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |